ArticleHuman gene therapy2022

Bispecific Antibody Expressed by an Oncolytic Herpes Simplex Virus Type 2 Can Transform Heterologous T Cells Into Uniform Tumor Killer Cells.

Jing Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.